Drug treatment of Diabetes in pregnancy
Phase 3
Recruiting
- Conditions
- Diabetes mellitus arising in pregnancy
- Registration Number
- RBR-3j3cktx
- Lead Sponsor
- Hospital da Mulher Prof. Dr. José Aristodemo Pinotti - CAISM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
Pregnant women diagnosed with diabetes type two or gestational diabetes; pregnant women that require medication for glycemic control; pregnant women that agree to participate of the study; pregnant women over 18 years old; pregnant women following in the prenatal care unit of our service
Exclusion Criteria
Pregnant women diagnosed with diabetes that do not require medication for glycemic control, pregnant women that cannot use any of the medication (insulin or metformin); pregnant women that refuse to participate of the study; pregnant women under 18 years old
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We expect that the glycemic control in the metformin group will be superior to the insulin group, which will be evalueted with fasting and post prandial glucose measurements
- Secondary Outcome Measures
Name Time Method We expect that gestational outcomes are better in the metformin group than in the insulin group, which will be evalueted by lower weight gain in pregnancy ;We expect that perinatal outcomes are better in the metformin group than the insulin group will be evalueted by less macrossomic newborns in the metformin group